Si-bone, Inc. revenue
Si-bone, Inc.'s revenue was $201m in fiscal 2025, up 20.2% on the year before. Since fiscal 2017 ($48.0m) it has grown at a compound 19.6% a year. Over the last twelve months it was $214m.
Revenue history
| Fiscal year | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 48 | 55 | 67 | 73 | 90 | 106 | 139 | 167 | 201 | 214 |
| Growth on the year before | — | +15.4% | +21.5% | +9.0% | +22.8% | +18.0% | +30.5% | +20.4% | +20.2% | — |
| Gross profit | 43 | 51 | 61 | 64 | 80 | 91 | 109 | 132 | 160 | 170 |
| Gross margin | 89.3% | 91.3% | 89.9% | 87.9% | 88.4% | 85.2% | 78.8% | 79.0% | 79.6% | 79.5% |
Where the revenue comes from
| Region | Revenue | Share | YoY |
|---|---|---|---|
| United States | $191M | 95.1% | ▲ 20.6% |
| Outside the US | $9.8M | 4.9% | ▲ 12.4% |
From Si-bone, Inc.'s 10-K filed February 24, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.
Revenue against peers
| Company | Revenue | Growth | 3-year growth a year |
|---|---|---|---|
| Si-bone, Inc. | $214m | 15.3% | 19.7% |
| Treace Medical Concepts, Inc. | $205m | -4.0% | 7.1% |
| Lakeland Industries Inc | $191m | -0.3% | 17.0% |
| Establishment Labs Holdings Inc. | $246m | 38.6% | 11.5% |
| Cerus Corp | $254m | 74.6% | 89.8% |
| Lemaitre Vascular Inc | $262m | 11.8% | 14.0% |
Compare with peers
- Treace Medical Concepts, Inc. revenue
- Lakeland Industries Inc revenue
- Establishment Labs Holdings Inc. revenue
- Cerus Corp revenue
- Lemaitre Vascular Inc revenue
Head to head: SIBN vs TMCILAKE vs SIBNESTA vs SIBN
More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies